Furthermore, our findings identified expression levels of CCR6 rather than T-bet, not only on atypical but also on classical MBCs, as a good predictor of increased risk of malaria. The induction of TH1-like CXCR3+ TFH cells was strongly correlated with increasing frequencies of IgM+IgD+ MBCs. 6). Young children with low levels of immunity are at greatest risk of symptomatic malaria (7C9). Naturally acquired immunity to parasites is often acquired after extended exposure to the parasite (10). This form of immunity is not sterilizing but prevents symptomatic episodes by substantially reducing parasite densities below the threshold capable of causing clinical illness (10). Compared with is acquired more rapidly compared with (9), and in endemic regions, morbidity peaks at an earlier age in malaria does not appear to be YM-90709 dependent on age (11). It is accepted that antibodies are a key component of clinical immunity to malaria. Seminal studies conducted decades ago established that passive transfer of immunoglobulin G (IgG) from clinically immune adults alleviates clinical symptoms and reduces parasite burden in nonimmune children (12, 13). Furthermore, antibodies against several blood-stage antigens have been found to be associated with protection from symptomatic and malaria (14C19), with roles that include inhibition of parasite invasion into the red blood cell and opsonization of parasites for phagocytosis by effector cells (20, 21). The acquisition of long-lived antibody-mediated immunity requires the establishment of germinal centers (GCs) in secondary lymphoid organs. In GCs, after interaction with cognate antigen, activated B cells undergo somatic hypermutation of their Ig genes followed by selection of B cell clones producing antibody with high affinity for antigen. GC function requires help from a subset of T cells named T follicular helper (TFH) cells (22). These cells YM-90709 orchestrate GC responses and promote the differentiation of naive B cells into long-lived plasma cells and memory B cells (MBCs), which circulate and become rapidly activated upon reencounter with their specific antigen (23). Because of the pivotal role that TFH cells and MBCs play in YM-90709 the induction and recall of antibody responses, recent studies in mouse models and human infection investigated these populations to establish associations between their functional capacity and mechanisms underlying the slow acquisition of immunity to malaria. MBCs specific for several and antigens have been observed in malaria-exposed individuals in different geographical regions (24C28). Although these cells were found to be short-lived in individuals residing in areas of high seasonal transmission (28), infection in mice, were found to upregulate the expression of the T helper 1 (TH1) cell-defining transcription factor T-bet in TFH cells, which inhibits their differentiation and results in reduced GC responses YM-90709 to infection (29). Similarly, symptomatic and malaria infections were found to induce the activation of circulating TH1-like TFH cells (30), with limited helper capacity (31), that were negatively associated with antibody responses to infection. While these studies support the idea that inflammatory responses induced by acute malaria have a detrimental impact on the TFH pool, recent findings in mice identified TH1 memory CD4+ T cells induced in response to infection capable of successfully sustaining B cell help (32), thus challenging the notion that TH1-polarized CD4+ T cells impair the development of long-lived antibody-mediated immunity. It is accepted that acute and malaria infections induce high frequencies of CD27CCD21C atypical MBCs (25, 33C37). Similar to circulating TFH cells observed in acute malaria, atypical MBCs also express variable levels of the TH1 transcription ETS2 factor T-bet (34, 35, 38). The role of atypical MBCs in malaria is controversial. Whereas some studies propose that these cells are an important source of parasite-specific antibodies (39) and contribute to protection from infection (40C42), other studies have disputed the effector capacity of these cells (34, 36) and instead proposed associations between T-bet+ atypical MBCs and symptomatic malaria (38). Most of our knowledge on immune responses to malaria originated from bulk population.